Table 1. Descriptive statistics of all patients in the analysis.
| Patients (n, (%)) | |
|---|---|
| Sex (%) | |
| Female | 21 (32.8) |
| Male | 41 (67.2) |
| Age (SD) | 52.92 (17.16) |
| Radiotherapy (%) | 50 (78.1) |
| > 55Gy | 46 (71.87) |
| < 55Gy | 4 |
| Chemotherapy (%) | 64 (100) |
| TMZ | 58 (90.6) |
| Lomustin | 5 (7.8) |
| Tacrolimus | 1 (1.56) |
| Surgery (%) | 64 (100) |
| Gross-Total Resection | 43 (67.1) |
| Partial Resection | 14 (21.8) |
| Biopsy | 7 (10.9) |
| MGMT (%) | 60 (93.7) |
| Not Methylated | 35 (54.68) |
| Methylated | 25 (39.06) |
| Not Evaluated | 8 (12.5) |
| IDH 1/2 Mutation (%) | 64 (100) |
| Mutation | 5 (7.8) |
| Wildtype | 59 (92.8) |
| Leukopenia (%) | 33 (51.5) |
| > Grade 3 | 3 (4.69) |
| Thrombopenia (%) | 36 (56.3) |
| > Grade 3 | 2 (3.13) |
| Long-Term Steroids | 9 (14.06) |
| Immune Suppressive Therapy | 2 (3.13) |
SD: Standard deviation